DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

AstraZeneca Pharma India Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 48 min ago·28 Jul 2026, 9:48 pm

Company NSE

AstraZeneca Pharma India Limited has submitted a certificate to the Exchange as required by SEBI regulations. This certificate is related to the company's compliance with the Depositories and Participants Regulations, 2018.

This development is a routine regulatory requirement for listed companies in India. It indicates that AstraZeneca Pharma India Limited is fulfilling its obligations under the SEBI regulations.

Investors should watch for any further updates from the company regarding its compliance with regulatory requirements. This information can provide insight into the company's governance and regulatory adherence.